Literature DB >> 25876771

Drug-induced glomerular disease: attention required!

Jai Radhakrishnan1, Mark A Perazella2.   

Abstract

Drugs and toxins frequently are associated with the development of various types of acute kidney disease and CKD. Although medications are a widely known cause of tubulointerstitial damage, drug-related glomerular injury is not well appreciated but nonetheless, important. Glomerular damage that occurs after exposure to medications can be caused by direct cellular injury involving the mesangial, endothelial, or visceral epithelial cells (podocytes). Examples include nodular glomerulosclerosis associated with smoking and endothelial injury with thrombotic microangiopathy from a number of medications. Podocyte injury with the development of a minimal change or FSGS lesion has also been described with various medications. Glomerulopathies may also be associated with drug-induced immune-mediated processes. Through various pathways, drugs may promote the formation of a number of antibodies, which may, ultimately, affect the glomerulus. Examples include lupus-like renal lesions and ANCA-related pauci-immune vasculitis. It is critical to recognize these conditions early, because in many patients, there is improvement in renal parameters on stopping the offending medication.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  GN; drugs; glomerular disease; nephrotoxicity

Mesh:

Year:  2015        PMID: 25876771      PMCID: PMC4491281          DOI: 10.2215/CJN.01010115

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  23 in total

Review 1.  Drug-induced glomerulopathies.

Authors:  Hassan Izzedine; Vincent Launay-Vacher; Edward Bourry; Isabelle Brocheriou; Svetlana Karie; Gilbert Deray
Journal:  Expert Opin Drug Saf       Date:  2006-01       Impact factor: 4.250

2.  Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis.

Authors:  Glen S Markowitz; Samih H Nasr; M Barry Stokes; Vivette D D'Agati
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-04       Impact factor: 8.237

Review 3.  Drug-induced thrombotic microangiopathy.

Authors:  Anaadriana Zakarija; Charles Bennett
Journal:  Semin Thromb Hemost       Date:  2005-12       Impact factor: 4.180

Review 4.  VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management.

Authors:  Hassane Izzedine; Christophe Massard; Jean Philippe Spano; François Goldwasser; David Khayat; Jean Charles Soria
Journal:  Eur J Cancer       Date:  2009-12-16       Impact factor: 9.162

5.  Idiopathic nodular glomerulosclerosis: a clinicopathologic study of 15 cases.

Authors:  Wei Li; Regina R Verani
Journal:  Hum Pathol       Date:  2008-08-12       Impact factor: 3.466

Review 6.  Bisphosphonate nephrotoxicity.

Authors:  Mark A Perazella; Glen S Markowitz
Journal:  Kidney Int       Date:  2008-08-06       Impact factor: 10.612

Review 7.  Nodular glomerulosclerosis in the nondiabetic smoker.

Authors:  Samih H Nasr; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2007-06-13       Impact factor: 10.121

8.  Gemcitabine nephrotoxicity and hemolytic uremic syndrome: report of 29 cases from a single institution.

Authors:  I Glezerman; M G Kris; V Miller; S Seshan; C D Flombaum
Journal:  Clin Nephrol       Date:  2009-02       Impact factor: 0.975

9.  High sirolimus levels may induce focal segmental glomerulosclerosis de novo.

Authors:  Emmanuel Letavernier; Patrick Bruneval; Chantal Mandet; Jean-Paul Duong Van Huyen; Marie-Noëlle Péraldi; Imed Helal; Laure-Hélène Noël; Christophe Legendre
Journal:  Clin J Am Soc Nephrol       Date:  2007-02-07       Impact factor: 8.237

10.  Development of focal segmental glomerulosclerosis after anabolic steroid abuse.

Authors:  Leal C Herlitz; Glen S Markowitz; Alton B Farris; Joshua A Schwimmer; Michael B Stokes; Cheryl Kunis; Robert B Colvin; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2009-11-16       Impact factor: 10.121

View more
  9 in total

Review 1.  [(Immuno‑)Pathology of drug side effects in the kidney].

Authors:  F Pfister; M Büttner-Herold; K Amann
Journal:  Pathologe       Date:  2018-11       Impact factor: 1.011

2.  Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review.

Authors:  Elisabetta Chessa; Matteo Piga; Alberto Floris; Mattia Congia; Ignazio Cangemi; Alessandro Mathieu; Alberto Cauli
Journal:  BioDrugs       Date:  2021-02-17       Impact factor: 5.807

3.  3D virtual histology of murine kidneys -high resolution visualization of pathological alterations by micro computed tomography.

Authors:  Jeannine Missbach-Guentner; Diana Pinkert-Leetsch; Christian Dullin; Roser Ufartes; Daniel Hornung; Bjoern Tampe; Michael Zeisberg; Frauke Alves
Journal:  Sci Rep       Date:  2018-01-23       Impact factor: 4.379

Review 4.  Anticancer Drug-Induced Acute Kidney Injury.

Authors:  Hassan Izzedine; Mark A Perazella
Journal:  Kidney Int Rep       Date:  2017-02-16

5.  Renal Subcapsular Transplantation of PSC-Derived Kidney Organoids Induces Neo-vasculogenesis and Significant Glomerular and Tubular Maturation In Vivo.

Authors:  Cathelijne W van den Berg; Laila Ritsma; M Cristina Avramut; Loes E Wiersma; Bernard M van den Berg; Daniëlle G Leuning; Ellen Lievers; Marije Koning; Jessica M Vanslambrouck; Abraham J Koster; Sara E Howden; Minoru Takasato; Melissa H Little; Ton J Rabelink
Journal:  Stem Cell Reports       Date:  2018-03-01       Impact factor: 7.765

6.  Secondary Membranous Nephropathy. A Narrative Review.

Authors:  Gabriella Moroni; Claudio Ponticelli
Journal:  Front Med (Lausanne)       Date:  2020-12-03

7.  Drug-induced kidney disease: a study of the Japan Renal Biopsy Registry from 2007 to 2015.

Authors:  Hitoshi Yokoyama; Ichie Narita; Hitoshi Sugiyama; Michio Nagata; Hiroshi Sato; Yoshihiko Ueda; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2015-11-21       Impact factor: 2.801

Review 8.  Preventing CKD in Developed Countries.

Authors:  Valerie A Luyckx; David Z I Cherney; Aminu K Bello
Journal:  Kidney Int Rep       Date:  2019-12-18

9.  Evidences of histologic thrombotic microangiopathy and the impact in renal outcomes of patients with IgA nephropathy.

Authors:  Precil Diego Miranda de Menezes Neves; Rafael A Souza; Fábio M Torres; Fábio A Reis; Rafaela B Pinheiro; Cristiane B Dias; Luis Yu; Viktoria Woronik; Luzia S Furukawa; Lívia B Cavalcante; Stanley de Almeida Araújo; David Campos Wanderley; Denise M Malheiros; Lectícia B Jorge
Journal:  PLoS One       Date:  2020-11-04       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.